Conclusions: 1. DAP can be safely incorporated in an AVICD devices for use in an hybrid therapy strategy for AF pts. 2. These devices can be effective for both AF prevention & termination. 3. Long term rhythm control can be achieved and documented by device datalogs in persistent and permanent AF.

Keywords

This study was conducted during Dr. Rao’s tenure as Research Fellow in Cardiac Electrophysiology at the Electrophysiology Research Foundation. Dr. Saksena is a consultant or advisor pacemaker, drug, and catheter device manufacturers.

Fuster V, Ryden LE, Asinger RW, Cannom DS etal., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American college of Cardiology/American Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 2001;38:1231–1266.CrossRefPubMedGoogle Scholar